U.S. Biotech/Pharma Sector Daily Observations Letter: February 12, 2018 – Kadmon Holdings (NYSE:KDMN)

Market and sector outlook:

The broad U.S. equities sector and the biotech sector rebounded today as we mentioned last week and then pulled back towards the end of the day. After a small pullback, the uptrend could likely resume in a day or so. Whether we will make new highs or go to new lows is unclear, but we are in favor of new lows (breaking Friday lows) and then new highs to end the 2009-2018 bull market (over next 6-9 months).

SPX RSI= 40.5 | IBB RSI= 42.05

Up on >5x volume (excluding penny stocks):

Dare Bioscience (DARE): 50% (out-licensed its topical sildefanil cream for female sexual arousal disorder)

HTG Molecular Diagnostics (HTGM): 18% (no clear news)

Apricus biosciences (APRI): 16.9% (upcoming PDUFA)

ADMA Biologics (ADMA): 3.2% (no clear news)

Upward reversal alert: (CTSO), (ZSAN)

Downward reversal alert: N/A

Day’s events’ outlook:

Kadmon Holdings (KDMN) was one of the most discussed biotech companies today after releasing encouraging early data from a phase 2…

Read more here

What do you think?

0 points
Upvote Downvote

Total votes: 0

Upvotes: 0

Upvotes percentage: 0.000000%

Downvotes: 0

Downvotes percentage: 0.000000%